152 related articles for article (PubMed ID: 36948666)
1. Biomarkers for the Detection and Surveillance of Renal Cancer.
Nolazco JI; Soerensen SJC; Chung BI
Urol Clin North Am; 2023 May; 50(2):191-204. PubMed ID: 36948666
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic and prognostic markers of renal cell carcinoma].
Spadaccino F; Netti GS; Rocchetti MT; Castellano G; Stallone G; Ranieri E
G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281759
[TBL] [Abstract][Full Text] [Related]
3. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
[TBL] [Abstract][Full Text] [Related]
4. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
5. Current trends in the molecular classification of renal neoplasms.
Young AN; Master VA; Amin MB
ScientificWorldJournal; 2006 Dec; 6():2505-18. PubMed ID: 17619725
[TBL] [Abstract][Full Text] [Related]
6. Current and Future Biomarkers in the Management of Renal Cell Carcinoma.
Reese S; Calderon L; Khaleel S; Hakimi AA
Urol Clin North Am; 2023 Feb; 50(1):151-159. PubMed ID: 36424079
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective.
Albiges L; Fay AP; McKay RR; Kaymakcalan MD; Choueiri TK
Surg Pathol Clin; 2015 Dec; 8(4):657-62. PubMed ID: 26612219
[TBL] [Abstract][Full Text] [Related]
8. Immunostaining characteristics of irisin in benign and malignant renal cancers.
Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S
Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.
Golovastova MO; Korolev DO; Tsoy LV; Varshavsky VA; Xu WH; Vinarov AZ; Zernii EY; Philippov PP; Zamyatnin AA
Curr Urol Rep; 2017 Jan; 18(1):3. PubMed ID: 28110463
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma and mimics: pathologic primer for radiologists.
Bai X; Wu CL
AJR Am J Roentgenol; 2012 Jun; 198(6):1289-93. PubMed ID: 22623540
[TBL] [Abstract][Full Text] [Related]
11. [Metabonome in Early Diagnosis of Renal Cell Carcinoma].
Wang Z; Zhang YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):709-713. PubMed ID: 31699205
[TBL] [Abstract][Full Text] [Related]
12. Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy.
Flitcroft JG; Verheyen J; Vemulkar T; Welbourne EN; Rossi SH; Welsh SJ; Cowburn RP; Stewart GD
BJU Int; 2022 Mar; 129(3):290-303. PubMed ID: 34570419
[TBL] [Abstract][Full Text] [Related]
13. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract][Full Text] [Related]
14. Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study.
Ito K; Mikami S; Kuroda N; Nagashima Y; Tatsugami K; Masumori N; Kondo T; Takagi T; Nakanishi S; Eto M; Kamba T; Tomita Y; Matsuyama H; Tsushima T; Nakazawa H; Oya M; Kimura G; Shinohara N; Asano T
Jpn J Clin Oncol; 2020 Oct; 50(11):1313-1320. PubMed ID: 33089867
[TBL] [Abstract][Full Text] [Related]
15. Tissue biomarkers in renal cell carcinoma: issues and solutions.
Di Napoli A; Signoretti S
Cancer; 2009 May; 115(10 Suppl):2290-7. PubMed ID: 19402057
[TBL] [Abstract][Full Text] [Related]
16. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
17. [Renal cell carcinoma].
Fornara P; Hoda MR
Urologe A; 2011 Sep; 50 Suppl 1():219-22. PubMed ID: 21837488
[TBL] [Abstract][Full Text] [Related]
18. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
[TBL] [Abstract][Full Text] [Related]
20. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
